Dieter Enkelmann

Swiss (born 1959), has been a Board Member of the Cosmo Pharmaceuticals NV since 2006. Dieter A. Enkelmann is Chief Financial Officer and member of the executive management board of Julius Baer Group Ltd., the largest independent private banking group in Switzerland, listed on the SIX Swiss Exchange. From 2003 to 2006 he was Chief Financial Officer of Barry Callebaut AG, the world’s leading manufacturer of high-quality cocoa, chocolate and confectionary products, which is listed on the SIX Swiss Exchange. From 1997 to 2003 he was at Swiss Re as head of finance of the business unit financial services and as head of corporate finance, treasury, and investor relations. From 1985 to 1997 he held several positions at Credit Suisse, both in Zurich and London. Dieter A. Enkelmann is a board member of iNNutriGEL AG, in Schlieren, Switzerland, and a member of the board and head of the compensation committee of SIX-listed GAM Holding Ltd., in Zurich, Switzerland. Julius Baer bank provides no services for the Company. He graduated from the University of Zurich, where he obtained a degree in law.